The Frequency of Tumor-infiltrating Tie–2-expressing Monocytes in Renal Cell Carcinoma: Its Relationship to Angiogenesis and Progression

Objective To examine the frequency of tumor-infiltrating Tie–2-expressing monocytes (TEMs) in renal cell carcinoma (RCC) and its association with microvessel density (MVD) and other clinical-pathologic features. Materials and Methods This study enrolled 65 consecutive patients with RCC treated with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urology (Ridgewood, N.J.) N.J.), 2013-10, Vol.82 (4), p.974.e9-974.e13
Hauptverfasser: Ji, Jindong, Zhang, Guangbo, Sun, Bo, Yuan, Hexing, Huang, Yuhua, Zhang, Jianglei, Wei, Xuedong, Zhang, Xuefeng, Hou, Jianquan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective To examine the frequency of tumor-infiltrating Tie–2-expressing monocytes (TEMs) in renal cell carcinoma (RCC) and its association with microvessel density (MVD) and other clinical-pathologic features. Materials and Methods This study enrolled 65 consecutive patients with RCC treated with radical nephrectomy. The frequency of tumor-infiltrating TEMs, which was defined as CD14+ Tie-2+ cells, was assessed using flow cytometry. MVD was measured by immunohistochemistry using anti-CD34 antibody. The association between clinicopathologic parameters, MVD, and the frequency of tumor-infiltrating TEMs in RCC was assessed. Results High frequency of tumor-infiltrating TEMs was significantly associated with advanced stage ( P  = .018), positive lymph nodes ( P  = .013), high grade ( P  = .019), and metastases ( P  = .006). Correlation analysis revealed that the frequency of TEMs was positively correlated with MVD. Conclusion Our findings revealed a significant association between prognostic tumor features, MVD, and the frequency of tumor-infiltrating TEMs in RCC and indicated that TEMs may play an important role in angiogenesis and progression of RCC.
ISSN:0090-4295
1527-9995
DOI:10.1016/j.urology.2013.05.026